{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:40Z","timestamp":1790996800459,"version":"4.1.0"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,10,6]]},"DOI":"10.1001\/jama.2020.16253","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T18:12:04Z","timestamp":1598897524000},"page":"1282","source":"Crossref","is-referenced-by-count":58,"title":["Emergency Use Authorizations During the COVID-19 Pandemic"],"prefix":"10.1001","volume":"324","author":[{"given":"Kyle","family":"Thomson","sequence":"first","affiliation":[{"name":"American Medical Association, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herschel","family":"Nachlis","sequence":"additional","affiliation":[{"name":"Department of Government, Rockefeller Center for Public Policy, Dartmouth College, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jvp200183r2","article-title":"Unwavering regulatory safeguards for COVID-19 vaccines.","author":"Shah","journal-title":"JAMA"},{"issue":"1","key":"jvp200183r5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19.","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"jvp200183r9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1001\/jama.2020.12461","article-title":"The development of COVID-19 vaccines.","volume":"324","author":"Lurie","year":"2020","journal-title":"JAMA"},{"key":"jvp200183r3"},{"key":"jvp200183r7","doi-asserted-by":"crossref","DOI":"10.1515\/9781400835119","volume-title":"Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA","author":"Carpenter","year":"2010"},{"key":"jvp200183r1","unstructured":"JAMA Network. COVID-19 and the FDA, with Commissioner Stephen Hahn, MD. Accessed August 3, 2020. https:\/\/www.youtube.com\/watch?v=UdmaU2-C_wE&feature=youtu.be"},{"key":"jvp200183r4","unstructured":"Emergency Use Authorization of medical products and related authorities: guidance for industry and other stakeholders. Published January 2017. Accessed August 3, 2020. https:\/\/www.fda.gov\/media\/97321\/download"},{"key":"jvp200183r6","unstructured":"Letter to Dr Rick Bright re: request for Emergency Use Authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. Published March 28, 2020. Accessed August 3, 2020. https:\/\/www.fda.gov\/media\/136534\/download"},{"key":"jvp200183r8","unstructured":"Hahn? SM. FDA commissioner: no matter what, only a safe, effective vaccine will get our approval. Washington Post. Published August 5, 2020. Accessed August 9, 2020. https:\/\/www.washingtonpost.com\/opinions\/fda-commissioner-no-matter-what-only-a-safe-effective-vaccine-will-get-our-approval\/2020\/08\/05\/e897d920-d74e-11ea-aff6-220dd3a14741_story.html"},{"key":"jvp200183r10","unstructured":"Development and licensure of vaccines to prevent COVID-19: guidance for industry. Published June 2020. Accessed August 3, 2020. https:\/\/www.fda.gov\/media\/139638\/download"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2770243\/jama_thomson_2020_vp_200183_1601660320.25186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T04:35:48Z","timestamp":1617078948000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2770243"}},"subtitle":["Lessons From Hydroxychloroquine for Vaccine Authorization and Approval"],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":10,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,10,6]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.16253","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,6]]}}}